Pulse Biosciences (PLSE)
(Delayed Data from NSDQ)
$15.54 USD
-0.02 (-0.13%)
Updated Aug 29, 2025 04:00 PM ET
After-Market: $15.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PLSE 15.54 -0.02(-0.13%)
Will PLSE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PLSE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PLSE
PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment
PLSE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PLSE
PLSE forms 50 Day Moving Average Support on August 28
Is PLSE showing upside potential? 50 Day Moving Average Support shows up after declining 1.83%
50 Day Moving Average Support appears for PLSE after 0.13% move
The technical outlook for PLSE is unchanged after it falls 6.27% on August 27
Pulse Biosciences Publishes Promising Thyroid Study Results